These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8693644)

  • 21. Androgen receptor is targeted to distinct subcellular compartments in response to different therapeutic antiandrogens.
    Whitaker HC; Hanrahan S; Totty N; Gamble SC; Waxman J; Cato AC; Hurst HC; Bevan CL
    Clin Cancer Res; 2004 Nov; 10(21):7392-401. PubMed ID: 15534116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of two non-steroidal antiandrogens on testicular function in prepubertal rats.
    Rulli SB; Gonzalez-Calvar SI; Campo S; Calandra RS
    J Androl; 1995; 16(3):225-32. PubMed ID: 7559155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen.
    Takeda K; Hara N; Nishiyama T; Tasaki M; Ishizaki F; Tomita Y
    BMC Cancer; 2016 May; 16():332. PubMed ID: 27225190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyflutamide may not always be a pure antiandrogen.
    Yeh S; Miyamoto H; Chang C
    Lancet; 1997 Mar; 349(9055):852-3. PubMed ID: 9121269
    [No Abstract]   [Full Text] [Related]  

  • 25. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z; Hoffmann J; Erdel M; Eder IE; Hobisch A; Hittmair A; Bartsch G; Utermann G; Schneider MR; Parczyk K; Klocker H
    Br J Cancer; 1999 Sep; 81(2):242-51. PubMed ID: 10496349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological and biological activities of pituitary FSH isoforms in prepubertal male rats: effect of antiandrogens.
    Rulli SB; Creus S; Pellizzari E; Cigorraga SB; Calandra RS; Campo S
    Neuroendocrinology; 1996 Jun; 63(6):514-21. PubMed ID: 8793893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
    J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity.
    Luo S; Martel C; Chen C; Labrie C; Candas B; Singh SM; Labrie F
    Urology; 1997 Dec; 50(6):913-9. PubMed ID: 9426723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific recognition of androgens by their nuclear receptor. A structure-function study.
    Poujol N; Wurtz JM; Tahiri B; Lumbroso S; Nicolas JC; Moras D; Sultan C
    J Biol Chem; 2000 Aug; 275(31):24022-31. PubMed ID: 10787411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
    Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
    J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
    Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ornithine decarboxylase activity and polyamine levels in the epididymis of prepubertal rat after antiandrogen administration.
    Rulli SB; Gonzalez-Calvar SI; Calandra RS
    Arch Androl; 1997; 38(2):163-71. PubMed ID: 9049038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of androgens and antiandrogens on the quantitative immunohistochemistry of gonadotrope cells in prepubertal male rats.
    Cónsole GG; Rulli SB; Riccillo FL; Calandra RS; Gómez Dumm CL
    Neuroendocrinology; 1999 Oct; 70(4):261-7. PubMed ID: 10529621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
    Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
    Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
    Furr BJ; Tucker H
    Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional AR signaling is evident in an in vitro mouse follicle culture bioassay that encompasses most stages of folliculogenesis.
    Lenie S; Smitz J
    Biol Reprod; 2009 Apr; 80(4):685-95. PubMed ID: 19074005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.
    Szelei J; Jimenez J; Soto AM; Luizzi MF; Sonnenschein C
    Endocrinology; 1997 Apr; 138(4):1406-12. PubMed ID: 9075695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of mutant androgen receptors by flutamide.
    Ishioka J; Hara S; Isaacs JT; Tomura A; Nishikawa K; Kageyama Y
    Int J Urol; 2009 May; 16(5):516-21. PubMed ID: 19389135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.